What's happening
This resolution urges the Governor to proclaim November 2018 as Alpha-1 Awareness Month in New York State.
Why it matters
Alpha-1 Antitrypsin Deficiency (Alpha-1) is a serious but underdiagnosed genetic condition. that can cause debilitating lung and liver diseases, often striking people in early to middle adulthood, but also affecting infants and sometimes leading to rare skin disorders.
Increased awareness can lead to earlier diagnosis and better outcomes,. as many individuals with Alpha-1 are unaware they have the condition; recognizing symptoms sooner allows for treatments like augmentation therapy and preventive health measures that can slow disease progression.
Awareness initiatives support affected individuals and families,. helping connect them with resources, peer support groups (like the Alpha-1 Foundation Support Group Network), and educational materials—reducing isolation and empowering proactive health management.
Highlighting Alpha-1 also encourages broader public health engagement,. prompting more research, policy attention, and coordinated action at the local, state, and national levels to address the needs of those living with rare genetic diseases.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Declare Alpha-1 Awareness Month
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Adopted
- Reported to calendar for consideration
- Referred to finance
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
Senate Resolution No. 5715 BY: Senator TEDISCO MEMORIALIZING Governor Andrew M. Cuomo to proclaim November 2018, as Alpha-1 Awareness Month in the State of New York WHEREAS, It is the custom of this Legislative Body to recognize official months that are set… Show allHide
Senate Resolution No. 5715 BY: Senator TEDISCO MEMORIALIZING Governor Andrew M. Cuomo to proclaim November 2018, as Alpha-1 Awareness Month in the State of New York WHEREAS, It is the custom of this Legislative Body to recognize official months that are set aside to increase awareness of serious diseases that affect the lives of citizens of New York State; and WHEREAS, Attendant to such concern, and in full accord with its long-standing traditions, this Legislative Body is justly proud to memorialize Governor Andrew M. Cuomo to proclaim November 2018, as Alpha-1 Awareness Month in the State of New York, in conjunction with the observance of National Alpha-1 Awareness Month; and WHEREAS, Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic condition which may result in serious lung disease or liver disease; it occurs when there is a severe lack of a protein in the blood called alpha-1 antitrypsin (AAT) which is mainly produced by the liver; and WHEREAS, The main function of AAT is to protect the lungs from inflammation caused by infection and inhaled irritants such as tobacco smoke; the low level of AAT in the blood occurs because the AAT is abnormal and cannot be released from the liver at the normal rate; this leads to a buildup of abnormal AAT in the liver which can cause liver disease; and WHEREAS, People with Alpha-1 antitrypsin deficiency usually develop the first signs and symptoms of lung disease between ages 20 and 50; the earliest symptoms are shortness of breath following mild activity, reduced ability to exercise, and wheezing; and WHEREAS, Other signs and symptoms can include unintentional weight loss, recurring respiratory infections, fatigue, and rapid heartbeat upon standing; affected individuals often develop emphysema; and WHEREAS, About 10 percent of infants with Alpha-1 develop liver disease; approximately 15 percent of adults will develop liver damage due to the formation of scar tissue in the liver; and WHEREAS, In rare cases, people with Alpha-1 develop a skin condition called panniculitis, which is characterized by hardened skin with painful lumps or patches; and WHEREAS, There are treatments and preventative measures that may slow the progression of lung disease and help take control of one's health; the specific therapy for the treatment of Alpha-1 related lung disease is augmentation therapy, the use of alpha-1 antitrypsin protein; and WHEREAS, The Alpha-1 Foundation Support Group Network is a collective of more than 80 affiliated support groups, dedicated to providing support, education and information to people affected by Alpha-1, and to extending the mission of the Alpha-1 Foundation; and WHEREAS, Under the luminous leadership of Richard Lovrich, Capital Region of New York Alpha-1 Support Group helps people develop an enhanced, healthier sense of personal identity and a connection with the large Alpha-1 community; and WHEREAS, It is imperative that there be greater awareness of this serious health condition, and more must be done to increase activity at the local, State and National levels; now, therefore, be it RESOLVED, That this Legislative Body pause in its deliberations to memorialize Governor Andrew M. Cuomo to proclaim November 2018, as Alpha-1 Awareness Month in the State of New York; and be it further RESOLVED, That copies of this Resolution, suitably engrossed, be transmitted to The Honorable Andrew M. Cuomo, Governor of the State of New York, and Richard Lovrich, Leader, New York Capital Region Alpha-1 Support Group.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.